
At Sobi, each person brings their unique talents to work as a team and make a difference. We are dedicated to developing and delivering innovative therapies to improve the lives of people who live with a rare disease. Our edge comes from our team of people and our commitment to patients.
Here at Sobi, our mission and culture get us excited to come to work every day, but here are a few more reasons to join our team:
The Governmental Affairs & Policy Manager, CEE is responsible for monitoring, analysing and anticipating policy and legislative developments at EU and local (CEE) level with potential impact on patient access, pricing, reimbursement and overall business sustainability
The role focuses on:
The position provides early policy intelligence, impact analysis and strategic insight to support business decision‑making and contributes to the development of relevant access and policy strategies, while also supporting countries in understanding policy changes and, where appropriate, strengthening argumentation or driving policy‑related change in a coordinated and compliant manner.
This is a regional strategic role, focused on analysis, foresight, coordination and guidance, not on direct lobbying or country‑level execution.
EU & CEE Policy Monitoring and Interpretation
Early Impact Analysis & Strategic Foresight
Regional Policy Positioning & Coordination
Support to Countries & Advocacy Enablement
Industry Associations & External Platforms
Cross‑functional Collaboration & Internal Alignment

Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases.
We are dedicated to capturing the scientific opportunities of our time. With our early roots in Sweden, we started as pioneers in haemophilia. Today we are an innovative leader within rare diseases with a global reach. Together we are bringing brilliant ideas to life.
Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2024, revenue amounted to SEK 26 billion. Sobi’s share (STO:SOBI) is listed on Nasdaq Stockholm. More about Sobi at sobi.com and LinkedIn.